Jenburkt Pharmaceuticals Ltd. - Research Center
524731 JENBURPH Group (X) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 4.41 | 4.59 | 4.59 | 4.59 | 4.59 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 117.98 | 112.79 | 93.88 | 75.41 | 72.88 |
| Loan funds | |||||
| Secured loans | 2.44 | 5.82 | 3.71 | 3.44 | 7.47 |
| Unsecured loans | - | - | - | - | - |
| Total | 124.83 | 123.20 | 102.18 | 83.44 | 84.93 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 32.43 | 30.70 | 30.50 | 27.74 | 26.38 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 21.99 | 19.30 | 19.95 | 17.99 | 16.79 |
| Net block | 10.45 | 11.40 | 10.55 | 9.74 | 9.59 |
| Capital work-in-progress | 0.96 | 0.21 | 0.38 | 2.10 | 0.99 |
| Investments | 11.18 | 7.96 | 6.75 | 4.07 | 5.38 |
| Net current assets | |||||
| Current assets, loans & advances | 119.23 | 123.38 | 102.70 | 88.16 | 86.87 |
| Less : current liabilities & provisions | 16.98 | 19.75 | 18.20 | 20.63 | 17.89 |
| Total net current assets | 102.25 | 103.63 | 84.50 | 67.53 | 68.98 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 124.83 | 123.20 | 102.18 | 83.44 | 84.93 |
| Notes: | |||||
| Book value of unquoted investments | - | - | 0.25 | 1.57 | 3.52 |
| Market value of quoted investments | 11.18 | 7.96 | 3.93 | 2.50 | 1.86 |
| Contingent liabilities | 19.55 | 16.61 | 16.48 | 16.61 | 16.58 |
| Number of equity sharesoutstanding (Lacs) | 44.13 | 45.89 | 45.89 | 45.89 | 45.89 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis